Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer
Marina Pekar‐Zlotin(Assaf Harofeh Medical Center), Nir Peled(Shaare Zedek Medical Center)
Cited by 146
Related Papers
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
|Journal of Thoracic Oncology|2018|661
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
|Clinical Cancer Research|2019|237